“melanoma” Archives

in
Entry Author Date Location
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 08/10/20 Boston
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
AstraZeneca Wins First FDA Drug Nod for NF1, a Rare Genetic Disorder 04/10/20 National
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas 03/24/20 San Francisco
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown 07/25/19 National
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
BioCryst Drops Idera Pharma Merger After Shareholders Veto Deal 07/10/18 Raleigh Durham
ASCO Wrap: Cancer Combos, Precision Meds, Stock Movers & More 06/05/18 National
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines 05/10/18 Indiana
Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer 05/09/18 Boston
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
BioCryst, Idera Plan Merger in Tie-Up of Rare Disease Drug Developers 01/22/18 Raleigh Durham
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More 01/12/18 National
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases 11/16/17 Boston
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Array Lands $31M in Licensing Deal with Japan’s Ono Pharma 06/01/17 Boulder/Denver
Cellectar Advances Drug Research With Pierre Fabre, Other Partners 11/18/16 Wisconsin
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
Big Deals in Texas (ZS Pharma, HomeAway, Gravitant) & Other News 11/09/15 Texas
DermTech Looks to Build on Alternative Test for Skin Cancer 11/05/15 San Diego
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Page 1 of 3 next page »